RETROPERITONEAL LYMPH NODE DISSECTION: CASE SERIES AND CONTEMPORARY LITERATURE PERSPECTIVES

Authors

  • Nadeem Bin Nusrat Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Assad ur Rehman Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Shujah Muhammad Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Nauman Zafar Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Asadullah Aslam Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Hassan Arshad Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Yasir Khan Department of Hepato-Pancreato-Biliary & Liver Transplantation, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Sarmad Imtiaz Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Moin Arshad Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Aadil Chaudhary Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan
  • Saira Imtiaz Department of Research, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan

Keywords:

Lymph node metastasis, Testicular cancer, germ cell tumour, Retroperitoneal lymph node dissection

Abstract

Purpose: Retroperitoneal lymph node dissection (RPLND) remains a part of the management of men with metastatic germ cell tumours and is infrequently performed. The purpose of this study was to review clinical outcomes and complications of RPLND performed at Pakistan Kidney and Liver Institute & Research Center (PKLI & RC), Lahore, using data of patients who underwent the procedure between August 15, 2022, and July 16, 2024, as well as compared the results with the previous studies.

Materials and Methods: This study is a retrospective case series analysis of all patients who had RPLND at PKLI & RC in the given time frame. Patients' demographics and medical history, surgical details, postoperative course, and follow-up data were recorded on a structured questionnaire.

Results: Five patients who were treated by RPLND were enrolled in the study. The average age was 30. 40 ± 3. 98 years on average, and the average length of stay in surgery was 256. 00 ± 85. 47 minutes. A postoperative complication was intraoperative blood loss which required transfusion in one case. Epidural analgesia was the main approach that was utilized in managing pain. The mean time spent on hospital visits was 7. 20 ± 1. 48 days. Several pathologies were seen including the mature cystic teratoma, teratoma and the mixed germ cell tumor.

Conclusion: It was observed that RPLND at PKLI & RC usually yielded good results with manageable complications after surgery. In view of the above findings, this study provides useful information on the procedural aspects and the postoperative management of RPLND in order to enhance patient care in the future. For these reasons, it is recommended that subsequent research be conducted with larger sample sizes as a means of cross-checking these findings and enhancing understanding of potential long-term effects.

Author Biography

Moin Arshad, Department of Urology, Pakistan Kidney and Liver Institute and Research Centre Lahore, Pakistan

 

 

References

References

Tran V, Gibson L, Sengupta S. Retroperitoneal lymph node dissection for germ cell tumour. Transl Androl Urol. 2020;9(6):3103-3111. doi:10.21037/tau-2019-suc-18.

Li R, Duplisea JJ, Petros FG, et al. Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer. Eur Urol Oncol. 2019. [Epub ahead of print]. doi:10.1016/j.euo.2019.01.014.

Gaddam SJ, Chesnut GT. Testicle Cancer. StatPearls [Internet]. StatPearls Publishing; 2023 [cited 2023 Aug 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563159/.

Crocetto F, Arcaniolo D, Napolitano L, et al. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. Int J Environ Res Public Health. 2021;18(16):8500. doi:10.3390/IJERPH18168500.

Zhang T, Ji L, Liu B, et al. Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases. Int J Clin Exp Pathol [Internet]. e-Century Publishing Corporation; 2018 [cited 2023 Sep 4];11(9):4622. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962990/.

Reese SW, Tully KH, Nabi J, et al. Temporal trends in the incidence of testicular cancer in the United States over the past four decades. Eur Urol Oncol. 2021;4(5):834-6. doi:10.1016/j.euo.2020.06.011.

Hale GR, Teplitsky S, Truong H, et al. Lymph node imaging in testicular cancer. Transl Androl Urol. 2018;7(5):864-74. doi:10.21037/tau.2018.07.18.

Herrera Ortiz AF, Fernández Beaujon LJ, García Villamizar SY, Fonseca López FF. Magnetic resonance versus computed tomography for the detection of retroperitoneal lymph node metastasis due to testicular cancer: a systematic literature review. Eur J Radiol Open. 2021;8:100372. doi:10.1016/j.ejro.2021.100372.

Sohaib SA, Koh DM, Barbachano Y, et al. MRI in the follow-up of testicular cancer: less is more. Anticancer Res. 2019;39(6):2963-8. doi:10.21873/anticanres.13427.

Pearce AK, Manson-Bahr D, Reid A, Huddart R, Mayer E, Nicol DL. Outcomes of postchemotherapy retroperitoneal lymph node dissection from a high-volume UK centre compared with a national data set. Eur Urol Open Sci. 2021;33:83-88. https://doi.org/10.1016/j.euros.2021.09.005.

Considine S, Heaney R, Conroy R, et al. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting. Ir J Med Sci. 2016;185(4):901-907. https://doi.org/10.1007/s11845-015-1394-2.

Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU Int. 2007 May;99(5):993-997. https://doi.org/10.1111/j.1464-410X.2007.06740.x.

Ghoreifi A, Mitra AP, McClintock G, et al. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study. Urol Oncol. 2023;41(2):111.e7-111.e14. https://doi.org/10.1016/j.urolonc.2022.11.006.

Li R, Duplisea JJ, Petros FG, et al. Robotic postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Eur Urol Oncol. 2021;4(4):651-658. https://doi.org/10.1016/j.euo.2019.01.014.

Downloads

Published

2026-01-14

How to Cite

1.
Nusrat NB, Rehman A ur, Muhammad S, Zafar N, Aslam A, Arshad H, et al. RETROPERITONEAL LYMPH NODE DISSECTION: CASE SERIES AND CONTEMPORARY LITERATURE PERSPECTIVES . J Ayub Med Coll Abbottabad [Internet]. 2026 Jan. 14 [cited 2026 Jan. 19];37(3):378-82. Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/14033